Unsupervised identification of asthma symptom subtypes supports treatable traits approach.
Journal:
Allergology international : official journal of the Japanese Society of Allergology
Published Date:
Jul 28, 2025
Abstract
BACKGROUND: Heterogeneity of asthma requires a personalized therapeutic approach. However, objective measurements, such as spirometry and fraction of exhaled nitric oxide (FeNO) for implementing treatable traits approach, are limited in low- and middle-income countries and non-specialist settings. To implement precision medicine even with minimal resources, we developed an algorithm using unsupervised machine learning techniques that estimates key treatable traits (airflow limitation, type 2 [T2] inflammation, and frequent exacerbations) based on an asthma patient-reported outcome (PRO).
Authors
Keywords
No keywords available for this article.